Atrás
46
También listada como
ORINF
OTC
Rango del Día
$37.99
$40.52
Rango de 52 Semanas
$25.95
$42.75
Volumen
7
Promedio 50D / 200D
$39.70
/
$38.02
Cierre Anterior
$41.04
Quick Summary
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (631 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 44.5 | 0.2 |
| P/B | 16.6 | 3.0 |
| ROE % | 42.0 | 3.6 |
| Net Margin % | 25.4 | 3.8 |
| Rev Growth 5Y % | 16.1 | 9.9 |
| D/E | 0.2 | 0.2 |
Precio Objetivo de Analistas
No hay cobertura de analistas disponible
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2027 |
$0.00
$0.00 – $0.00
|
1.92B | 0 |
| FY2026 |
$2.30
$2.22 – $2.38
|
2.22B | 1 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-12 | N/A | $1.08 | — |
| 2025-10-28 | N/A | $0.40 | — |
| 2025-07-18 | N/A | $0.33 | — |
| 2025-04-23 | N/A | $0.23 | — |
| 2025-02-25 | N/A | $0.28 | — |
| 2024-10-29 | N/A | $0.63 | — |
| 2024-08-08 | N/A | $0.17 | — |
| 2024-04-25 | N/A | $0.17 | — |
Dividend History
7 yr streakYield
0.01%
Payout Ratio
0.48%
Growth (3Y)
-9.50%
Growth (5Y)
-17.42%
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Mar 26, 2026 | Apr 17, 2026 | $0.20 | 0.95% |
| Oct 16, 2025 | Nov 07, 2025 | $0.17 | 1.58% |
| Apr 07, 2025 | Apr 29, 2025 | $0.46 | 3.17% |
| Oct 16, 2024 | Nov 07, 2024 | $0.44 | 3.32% |
| Mar 21, 2024 | Apr 18, 2024 | $0.44 | 2.43% |
| Mar 23, 2023 | Apr 17, 2023 | $0.87 | 3.31% |
| Mar 24, 2022 | Apr 18, 2022 | $0.85 | 4.28% |
| Mar 26, 2021 | Apr 22, 2021 | $0.89 | 4.34% |
| May 07, 2020 | Jun 01, 2020 | $0.81 | 4.34% |
| Mar 26, 2020 | Apr 20, 2020 | $0.83 | 4.47% |
| Mar 27, 2019 | Apr 19, 2019 | $0.84 | 4.88% |
| Mar 21, 2018 | Apr 13, 2018 | $0.89 | 5.60% |
| Mar 22, 2017 | Apr 17, 2017 | $0.82 | 3.79% |
| Mar 22, 2016 | Apr 14, 2016 | $0.74 | 4.38% |
Puntos Clave
Revenue grew 16.07% annually over 5 years — strong growth
Earnings grew 45.67% over the past year
ROE of 41.98% indicates high profitability
Net margin of 25.43% shows strong profitability
Debt/Equity of 0.24 — conservative balance sheet
Generating 219.20M in free cash flow
Crecimiento
Revenue Growth (5Y)
16.07%
Revenue (1Y)22.50%
Earnings (1Y)45.67%
FCF Growth (3Y)898.18%
Calidad
Return on Equity
41.98%
ROIC29.80%
Net Margin25.43%
Op. Margin33.43%
Seguridad
Debt / Equity
0.24
Current Ratio2.40
Interest Coverage75.58
Valoración
P/E Ratio
44.48
Forward P/E17.85
P/B Ratio16.64
EV/EBITDA34.07
Dividend Yield0.01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 22.50% | Revenue Growth (3Y) | 26.02% |
| Earnings Growth (1Y) | 45.67% | Earnings Growth (3Y) | 48.88% |
| Revenue Growth (5Y) | 16.07% | Earnings Growth (5Y) | 25.49% |
| Profitability | |||
| Revenue (TTM) | 1.89B | Net Income (TTM) | 480.55M |
| ROE | 41.98% | ROA | 23.91% |
| Gross Margin | 64.20% | Operating Margin | 33.43% |
| Net Margin | 25.43% | Free Cash Flow (TTM) | 219.20M |
| ROIC | 29.80% | FCF Growth (3Y) | 898.18% |
| Safety | |||
| Debt / Equity | 0.24 | Current Ratio | 2.40 |
| Interest Coverage | 75.58 | ||
| Dividends | |||
| Dividend Yield | 0.01% | Payout Ratio | 0.48% |
| Dividend Growth (3Y) | -9.50% | Dividend Growth (5Y) | -17.42% |
| Consecutive Div Years | 7 yrs | ||
| Valuation | |||
| P/E Ratio | 44.48 | Forward P/E | 17.85 |
| P/B Ratio | 16.64 | P/S Ratio | 11.31 |
| PEG Ratio | -1.35 | Forward PEG | N/A |
| EV/EBITDA | 34.07 | Fwd EV/EBITDA | 30.29 |
| Forward P/S | 9.62 | Fwd Earnings Yield | 5.60% |
| FCF Yield | 1.03% | ||
| Market Cap | 21.37B | Enterprise Value | 21.52B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.89B | 1.54B | 1.19B | 1.34B | 1.04B |
| Net Income | 480.55M | 329.90M | 216.80M | 349.50M | 193.80M |
| EPS (Diluted) | 0.86 | 1.18 | 0.77 | 1.25 | 0.69 |
| Gross Profit | 1.21B | 946.40M | 657.80M | 849.00M | 593.50M |
| Operating Income | 631.60M | 416.60M | 274.90M | 439.60M | 243.30M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 2.01B | 1.63B | 1.44B | 1.50B | 1.11B |
| Total Liabilities | 725.40M | 624.10M | 548.50M | 595.50M | 366.10M |
| Shareholders' Equity | 1.28B | 1.01B | 890.10M | 908.10M | 747.90M |
| Total Debt | 305.27M | 327.30M | 200.10M | 214.00M | 108.50M |
| Cash & Equivalents | 160.90M | 205.60M | 106.70M | 332.60M | 216.70M |
| Current Assets | 1.34B | 1.02B | 825.30M | 878.60M | 690.20M |
| Current Liabilities | 560.30M | 273.40M | 264.80M | 275.50M | 209.20M |
Puntuaciones de Estrategias
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#105 of 158
Actividad Reciente
Entró
Growth Investing (Philip Fisher)
Mar 24, 2026